Answers are grounded in this paper and cite their sources.
Since the development of hybridoma technology over three decades ago, numerous monoclonal antibodies have been produced and the use of monoclonal antibodies has become one of the major breakthroughs in medicine. Significant progress has been made on new technologies for generating human monoclonal antibodies. This review serves as an introduction to the immortalization of antigen-specific human B cell and hybridoma technologies, phage display platform, the use of transgenic mice, and the generation of monoclonal antibodies from single B cells.
No takes yet. Share an insight, caveat, or question.
Shixia Wang (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: